Stay updated on PATHWay Study: Adjuvant Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A site-wide banner announces updates about NIH’s transition from using the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T12:37:49.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T11:59:37.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T12:51:14.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The study detail page now shows a 403 Forbidden error, preventing access to the page content. This indicates an access or server issue rather than a content update to the study details.
    Difference
    0.5%
    Check dated 2026-09-27T17:14:31.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page is now a 403 Forbidden error page, replacing the study details with an access-denied message. The header and footer remain visible, indicating a blocked access scenario rather than a content update.
    Difference
    19%
    Check dated 2026-09-20T11:21:07.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added revision tag v3.6.6 and removed revision v3.6.5, updating the page’s version history. This update is metadata-related and does not alter content or functionality.
    Difference
    0.1%
    Check dated 2026-08-29T23:35:36.000Z thumbnail image

Stay in the know with updates to PATHWay Study: Adjuvant Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page.